Organizers of the TRUMP memecoin are hosting a contest where 185 top holders can attend a Nov. 22 dinner with former President Donald Trump, with VIP perks and prizes like gold watches for top holders. Despite the event, the token trades about 97% below its peak, with holders collectively losing $3.81 billion as of June. U.S. senators have called for an SEC investigation into the token's financial dealings, citing conflicts of interest and investor losses. The contest uses a time-weighted leaderboard to reward sustained holdings, but selling below certain levels may forfeit VIP benefits. This follows previous dinners that drew congressional scrutiny over foreign ownership and potential insider benefits.
The TRUMP memecoin contest for top holders is notable amid a broader cryptocurrency market where only 14 of 50 major coins rose today. As of Oct 02, 2026 00:23 WIB, Pluang data shows ZIL (Zilliqa) at Rp63 with a 3.19% decline and a typical hold time of 132 days, VET (VeChain) at Rp156 down 3.16% with 147 days hold, and ATOM (Cosmos) at Rp30,952 down 2.74% with 60 days hold. Pluang order activity indicates strong selling pressure on ZIL (92% Sell) and a majority buying interest on ATOM (78% Buy).
Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...
RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report ...
Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...
